Dan Ouyang

• Dan Ouyang is a partner in the Beijing and Hong Kong offices of Wilson Sonsini Goodrich & Rosati, where she leads the capital market practice in the Greater China group. Dan has extensive experience with U.S. and Hong Kong equity offerings, Rule 144A and Reg S bond offerings, and private equity and M&A transactions. She has represented corporate clients across a range of industries, including technology, healthcare, and entertainment, in more than 100 IPOs and follow-on offerings in the U.S. and Hong Kong.
  Dan started her legal career in New York, and prior to joining the firm, Dan was a partner at a large international firm’s Beijing office. She was also previously a journalist at China Central Television and China Radio International.
  Dan is a native speaker of Mandarin Chinese and is fluent in English.

Hong Kong Capital Markets

• Represented the underwriters in Black Sesame International Holding Limited’s Hong Kong IPO and listing, the first-filed Chapter 18C listing in Hong Kong
• Represented WuXi XDC in its spin-off from Wuxi Biologics and its HK$4.07 billion Hong Kong IPO and listing
• Represented the issuer in Baiwang Co., Ltd.’s Hong Kong IPO and listing
• Represented the issuer in Dida Inc.’s Hong Kong IPO and listing
• Represented the issuer in Concord Healthcare Group Co., Ltd’s Hong Kong IPO and listing
• Represented the issuer in Xiamen Yan Palace Bird’s Nest Industry Co., Ltd.’s Hong Kong IPO and listing

U.S. Capital Markets

• Represented Cheche Group Inc. in its de-SPAC listing on Nasdaq
• Represented BitFuFu Inc. in its US$1.5 Billion de-SPAC listing on Nasdaq
• Represented the issuer in QuantaSing Group Limited's IPO and Nasdaq Listing

• Capital markets: Equity
• M&A
• Private equity

• Tech and telecoms
• Automotive
• Healthcare
• Pharma and life sciences
• Consumer goods and services

• J.D., Cornell Law School
• M.A., Cornell University
• B.A., Peking University